BARRIER COATINGS FOR FLUIDS CONTACTING MEDICAL DEVICES

• US 20110152820A1
• Filed: 12/21/2010
• Published: 06/23/2011
• Est. Priority Date: 12/22/2009
• Status: Abandoned Application

• Current Assignee: Medtronic Minimed Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Minimed Incorporated (Medtronic Plc)
• Inventors: Dang, Kiem, Chattaraj, Sarnath, Gulati, Poonam S.
• Application Number:
  US12/974,914
• Publication Number:
  US 20110152820A1
• Time in Patent Office: Days
• US Class Current: 604/403
• CPC Class Codes: A61M 5/14546 Front-loading type injectors

Abstract

The invention relates to methods and materials that, for example, function to increase the barrier properties of containers including polymeric drug medication reservoirs and related containers such as infusion set tubing. Embodiments of the invention include aqueous container systems having containers coated with a composition selected to have one or more material properties including an ability to reduce the diffusion or permeation of compounds such as oxygen, carbon dioxide, and preservatives (e.g. phenol, benzyl alcohol and m-cresol) into or through a wall of the container.

Claims

1. An aqueous container system comprising:

a container formed from a polymeric material;

an aqueous solution disposed within the container and comprising a polypeptide combined with a compound selected for its ability to preserve a biological activity of the polypeptide;

wherein a surface of the container is coated with a layer of material selected for its ability inhibit diffusion or permeation of the compound and gases into or through the container.

2. The aqueous container system of claim 1, wherein the polymeric material comprises:

a polyethylene;

a polypropylene;

a polyester;

a cyclic olefin;

a polyurethane;

a poly(vinylchloride);

a polyamide;

a polycarbonate;

a polyacrylate;

a polystyrene;

a polyimide;

a polysulfone;

a poly ether ether ketone (PEEK);

a silicone;

or

a co-polymer material composed of aliphatic cyclic or bicylic hydrocarbons with 5 to 7 membered ring or rings, and ethylene or propylene.

3. The aqueous container system of claim 1, wherein the coating layer comprises:

a poly(p-xylylene) compound;

a silicon compound;

a fluoropolymer compound;

a ethylene vinyl alcohol compound;

a polyvinylidine compound;

a tetrahedral amorphous carbon compound;

or a metal compound.

4. The aqueous container system of claim 1, wherein the compound comprises an antimicrobial agent.

5. The aqueous container system of claim 1, wherein the compound comprises a phenol, a benzyl alcohol or a cresol.

6. The aqueous container system of claim 1, wherein the polypeptide comprises an insulin.

7. The aqueous container system of claim 1, wherein the container comprises a medication reservoir or infusion set tubing.

8. The aqueous container system of claim 1, wherein the coating layer is disposed between a first layer and a second layer of polymeric material.

9. The aqueous container system of claim 1, wherein the polymeric material and the coating layer are transparent.

10. A method of inhibiting loss of a biological activity of a polypeptide stored within a container, comprising storing the polypeptide within an aqueous container system comprising:

a container formed from a polymeric material;

an aqueous solution disposed within the container and comprising the polypeptide combined with a compound selected for its ability to preserve a biological activity of the polypeptide;

wherein a surface of the container is coated with a layer of material selected for its ability to inhibit diffusion of the compound and gases into or through the container so that the compound is maintained at a concentration sufficient to inhibit loss of a biological activity of the polypeptide.

11. The method of claim 10, wherein the polypeptide is stored at room temperature for at least 24, 28 or 72 hours prior to administration.

12. The method of claim 10, wherein the container is a medication reservoir disposed within a medication infusion pump having dimensions smaller than 15×

15 centimeters and designed to be worn by a user during daily activities.

13. The method of claim 12, wherein, wherein the medication infusion pump is operably coupled to an interface that facilitates its attachment to the user, wherein the interface comprises a clip, a strap, a snap, a clamp or an adhesive strip.

14. The method of claim 10, wherein the polypeptide comprises insulin and the container comprises a medication reservoir or infusion set tubing.

15. A method of making an aqueous container system comprising:

forming a container from a polymeric material;

coating a surface of the container with a layer of material selected for its ability to function as a barrier that inhibits diffusion of compounds and gases into or through the container such that compounds can maintained at a concentration sufficient to inhibit loss of a biological activity of a polypeptide disposed within the container;

disposing an aqueous solution within the container, wherein the aqueous solution comprises a polypeptide combined with a compound selected for its ability to preserve a biological activity of the polypeptide;

so that an aqueous container system is made.

16. The method of claim 15, wherein the surface of the container is modified a process comprising plasma surface treatment.

17. The method of claim 15, wherein the surface of the container is modified by a process comprising vapor deposition.

18. The method of claim 15, wherein the surface of the container is coated with the layer of material at a pressure at least 10% below atmospheric pressure.

19. The method of claim 15, wherein the surface of the container is coated with the layer of material comprising:

a poly(p-xylylene) compound;

a silicon compound;

a fluoropolymer compound;

a ethylene vinyl alcohol compound;

a polyvinylidine compound;

a tetrahedral amorphous carbon compound;

or a metal compound; and

the polymeric container material comprises;

a polyethylene;

a polypropylene;

a polyester;

a cyclic olefin;

a polyurethane;

a poly(vinylchloride);

or

a co-polymer material composed of aliphatic cyclic or bicylic hydrocarbons with 5 to 7 membered ring or rings, and ethylene or propylene.

20. The method of claim 15, wherein the polypeptide comprises an insulin and the container comprises a medication reservoir or infusion set tubing.